Jul 14 |
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
|
Jul 6 |
Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)
|
Jul 6 |
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
|
Jun 18 |
Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play
|
May 28 |
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
|
May 27 |
Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation
|
May 23 |
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
|
May 15 |
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
|
May 13 |
Apogee Therapeutics reports Q1 results
|
May 13 |
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
|